ClinicalTrials.gg
Drug

Talampanel clinical trials

studies test it
12
open now
0
in phase 3
0
first study started
2000

How each study uses talampanel is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Talampanel
10

Development codes

LY300164
1
TV-7600
1

Studies by the year they started

12 studies that test it; most in 2003 (3)

Studies that test talampanel, by start year
YearStudies
20001
20021
20033
20052
20061
20081
20093

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
10

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 4

Teva Branded Pharmaceutical Products R&D, Inc. (8) · National Institute of Neurological Disorders and Stroke (NINDS) (3) · National Institutes of Health Clinical Center (CC) (1)

Studies

Open first, then newest update. How each study uses talampanel is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 12

Codes

What other systems call talampanel · ClinicalTrials.gg INT003769

  • MeSH (NLM) C085266talampanelOne source NLM
  • UNII (FDA) CVS43XG1L5TALAMPANELConfirmed FDA, NLM, Wikidata
  • Wikidata Q7678869talampanelConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C38139TalampanelOne source FDA
  • DrugBank DB04982One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.